These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5673717)

  • 1. Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1968 Sep; 163(1):75-83. PubMed ID: 5673717
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced stimulant effects of d-amphetamine on the spontaneous locomotor activity of rats treated with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1967 Oct; 158(1):140-9. PubMed ID: 6054074
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of the central effects of d-amphetamine by amantadine. II.
    Prepas S; Menon MK; Clark WG
    Arzneimittelforschung; 1975 May; 25(5):780-2. PubMed ID: 1242323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced stimulant properties of (+)-amphetamine after chronic reserpine treatment in the rat: mediation by hypophagia and weight loss.
    Fibiger HC; Trimbach C; Campbell BA
    Neuropharmacology; 1972 Jan; 11(1):57-67. PubMed ID: 5060518
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of d-amphetamine sulphate in combination with CNS depressants on spontaneous motor activity of mice.
    Sethy VH; Naik PY; Sheth UK
    Psychopharmacologia; 1970 Aug; 18(1):19-25. PubMed ID: 5523373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reserpine potentiation of a d-amphetamine effect].
    Boissier JR; Lwoff JM; Simon P
    Act Nerv Super (Praha); 1967 May; 9(2):160-2. PubMed ID: 6038244
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of d- and 1-amphetamine on spontaneous motor activity in mice.
    Maickel RP; Levine RM; Quirce CM
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):711-4. PubMed ID: 4420179
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine.
    Andén NE; Jackson DM
    J Pharm Pharmacol; 1975 Sep; 27(9):666-70. PubMed ID: 241810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Central stimulant action of fenfluramine in the rat.
    Everitt BJ; Hacket NB; Rand MJ
    Br J Pharmacol; 1972 Feb; 44(2):342P-343P. PubMed ID: 4668611
    [No Abstract]   [Full Text] [Related]  

  • 13. Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.
    Simola N; Tronci E; Pinna A; Morelli M
    Amino Acids; 2006 Nov; 31(4):359-63. PubMed ID: 16874467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial suppression of the locomotor stimulant response to dexamphetamine in rats exposed to a novel environment.
    Miller AA; Sethna DM; Young PA
    Br J Pharmacol; 1970 May; 39(1):230P-232P. PubMed ID: 5420122
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
    Vanderwolf CH; Robinson TE; Pappas BA
    Brain Res; 1980 Nov; 202(1):65-77. PubMed ID: 6968619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of several methods for recording spontaneous motor activity in mice under drug effects.
    Banerjee U; Geh SL
    Indian J Physiol Pharmacol; 1976; 20(2):53-8. PubMed ID: 965076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
    Aceto MD; Harris LS; Lesher GY; Pearl J; Brown TG
    J Pharmacol Exp Ther; 1967 Nov; 158(2):286-93. PubMed ID: 4383638
    [No Abstract]   [Full Text] [Related]  

  • 18. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine treatment produces persistent increases in amphetamine-stimulated locomotor activity in periadolescent male but not female or adult male rats.
    Collins SL; Montano R; Izenwasser S
    Brain Res Dev Brain Res; 2004 Nov; 153(2):175-87. PubMed ID: 15527885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats.
    Bevins RA; Klebaur JE; Bardo MT
    Behav Pharmacol; 1997 Jun; 8(2-3):113-23. PubMed ID: 9833007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.